Cancer Care Portal | Latest News, Research, and Support

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

News

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Editor - February 11, 2026

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

News

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

Editor - February 11, 2026

Being robbed is simply part of life.Once I was in grammar college, little girls and boys would copy off my exams, stealing my solutions to...

Vital Information

News

FDA Clears PD-L1 Check to Information Keytruda Use in Ovarian Most cancers

News

MRD Testing Could Supply Peace of Thoughts to Breast Most cancers Survivors

News

A Household’s Power Via Liver Most cancers and Residing Donation

News

Why Subcutaneous Darzalex Faspro Issues for Sufferers With A number of Myeloma

News

From Missed Indicators to Second Possibilities After a Liver Most cancers Prognosis

Editor - February 10, 2026

Keytruda Combo Accredited for Platinum-Resistant Ovarian Most cancers

Editor - February 10, 2026

Chris Draft Shares Steps to Assist Sufferers Regain Management After Most cancers

Editor - February 10, 2026

FDA Quick Observe Designation Highlights New Possibility in Superior Liver Most cancers

Editor - February 10, 2026

In search of a Dose of Hope Amidst Most cancers

Editor - February 10, 2026

FDA Clears Part 2b Research of Teverelix in Superior Prostate Most cancers

Editor - February 10, 2026

When Most cancers Care Turns into a Logistical Balancing Act

Facts

Research Hyperlinks Drug Remedy to Fewer Sizzling Flashes Throughout Prostate Most cancers Care

February 9, 2026

Why Breast Most cancers Care Is not One Measurement Matches All

February 9, 2026

Mother of 4 Shares Story of Her Breast Most cancers Prognosis

February 9, 2026

Most cancers Anniversaries Good and Unhealthy

February 9, 2026

A Liver Most cancers Journey Marked by Persistence, Household and Hope

February 9, 2026

FDA Grants Designation to Immunotherapy KB707 for Superior NSCLC

February 9, 2026

Latest Articles

News

Understanding High quality of Life Priorities in Later-Line Colon Most cancers

Editor - January 11, 2026

Dr. Thejus Jayakrishnan sat down with CURE on the 2026 ASCO Gastrointestinal Cancers Symposium to debate analysis he offered evaluating how sufferers...

News

A Decade of Affected person Proactivity and Doctor Partnership

Editor - January 11, 2026

Mayra Andujar-Delgado is grateful to her doctor, Dr. Faseeh Khaja, for the way he saved each her and her caregiver, which was...

News

FDA Utility Submitted for Rusfertide Therapy in Polycythemia Vera

Editor - January 10, 2026

Takeda and Protagonist Therapeutics have introduced the submission of a brand new drug software to the U.S. Meals and Drug Administration (FDA),...

News

Canines Have Close to-Most cancers Misses Too

Editor - January 10, 2026

New Yr’s Eve is a time for celebration and pleasure, and I’m going to discover the lighter aspect of most cancers: my...

News

High 5 Breast Most cancers Tales of 2025: Analysis, Therapies and Care

Editor - January 10, 2026

All through 2025, a number of research and occasions highlighted necessary developments in breast most cancers care, from new therapy choices to...

1...313233...1,671 Page 32 of 1,671

The Cancer

Don't Miss

Vital Information

Facts

Latest Articles

Hot Topics

Quick Links

Must Read

Popular Articles